APA (7th ed.) Citation

Wu, Y., Xu, M., Cao, Z., Yang, C., Wang, J., Wang, B., . . . Chen, X. (2019). Heterozygous Ldlr-Deficient Hamster as a Model to Evaluate the Efficacy of PCSK9 Antibody in Hyperlipidemia and Atherosclerosis. International journal of molecular sciences, 20(23), 5936. https://doi.org/10.3390/ijms20235936

Chicago Style (17th ed.) Citation

Wu, Yue, et al. "Heterozygous Ldlr-Deficient Hamster as a Model to Evaluate the Efficacy of PCSK9 Antibody in Hyperlipidemia and Atherosclerosis." International Journal of Molecular Sciences 20, no. 23 (2019): 5936. https://doi.org/10.3390/ijms20235936.

MLA (9th ed.) Citation

Wu, Yue, et al. "Heterozygous Ldlr-Deficient Hamster as a Model to Evaluate the Efficacy of PCSK9 Antibody in Hyperlipidemia and Atherosclerosis." International Journal of Molecular Sciences, vol. 20, no. 23, 2019, p. 5936, https://doi.org/10.3390/ijms20235936.